Lifearc funds Covid-19 drug screening hub at the University of Glasgow
Jan 06, 2021: "A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University of Glasgow...
FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines
January 04, 2021: "Two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing COVID-19 disease in adults.
Allergy Therapeutics begins peanut allergy vaccine study
January 05, 2021: "Speciality allergy-focussed pharmaceutical company Allergy Therapeutics announced on Tuesday that an ex-vivo biomarker study of blood samples from peanut allergy patients...
AZ’s Farxiga granted Priority Review in US for chronic kidney disease
January 06, 2021: "AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney disease...
AstraZeneca’s COVID-19 vaccine authorised in five other countries
January 06, 2021: AstraZeneca’s COVID-19 vaccinehas been granted emergency use authorisation in India as well as Argentina, Dominican Republic, El Salvador, Mexico...
New COVID-19 test gives positive result in just a few minutes
Jan 05, 2021: "A new COVID-19 test that reduces testing time from 30 minutes to less than five and delivers accurate results...
Angelini Pharma acquires CNS specialist Arvelle Therapeutics
Jan 04, 2021: "Angelini Pharma, an international pharmaceutical company which is a part of the private Italian Angelini Group – and Arvelle Therapeutics,...
EMA launches review of BMS’ Opdivo(nivolumab) for oesophageal cancer
January 04, 2020: "Bristol Myers Squibb announced that the European Medicines Agency (EMA) validated its Marketing Authorization Application (MAA) for Opdivo (nivolumab) as an...
Atacand divestment to Cheplapharm in more than 70 countries completed
January 04, 2021: "AstraZeneca has completed the divestment of commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide)...
Covaxin and Covishield got approval in India for emergency use
On 03-Jan-2021, Drug controller general of India, Dr V.G. Somani has announced in a press conference that two COVID19 vaccines (Covaxin and...
AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK
December 30, 2020: "AstraZeneca’s COVID-19 vaccine has been approved for emergency supply in the UK, with the first doses being released so...
Coronavirus (COVID-19) Update: December 28, 2020
December 28, 2020: "The U.S. FDA announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
Most Read
AZ’s Symbicort Turbuhaler approved as an anti-inflammatory reliever in mild asthma
January 26, 2021: "AstraZeneca’s Symbicort Turbuhaler (budesonide/formoterol 160/4.5mcg) has been approved in China as an anti-inflammatory reliever to be taken as-needed in response to...
Calquence approved in Japan for the treatment of relapsed or refractory chronic lymphocytic leukaemia
January 25, 2021: "AstraZeneca’s Calquence (acalabrutinib), a next-generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in Japan for the treatment of adult...
What is the process for Submission of Synopsis?
1.1 a. "Prior to submission of a thesis synopsis, a comprehensive assessment of the research work should be carried out by a...
COVAX Announces new agreement, plans for first deliveries
January 22, 2021: COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income...
